A study showed that injection of anti-NF antibodies from patients with CIDP to the experimental autoimmune neuritis (EAN) model could enhance and prolong an ongoing neuritis, but injection of anti-NF antibodies to the control group is not pathogenic (Ng et al., 2012). The gene discussed is NFASC; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.